Cover Image

Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report

Saved in:

Bibliographic Details
Main Authors:	Omar Najjar (Author), Aaron Varghese (Author), Maryam Shahi (Author), Russell Vang (Author), Stephanie Gaillard (Author), Thomas Smith (Author), Amanda N. Fader (Author)
Format:	Book
Published:	Elsevier, 2020-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
by: Angela L. Liang, et al.
Published: (2021)

Systematic review of economic evaluations of aromatase inhibitors in estrogen receptor-positive breast cancer: quality evaluation
by: Maha F. Althuwaibi, et al.
Published: (2023)

Combined trastuzumab and radiation therapy for HER2-positive uterine serous carcinoma: A case report
by: SPH Mao, et al.
Published: (2023)

Aromatase expression and role of estrogens in male gonad : a review
by: Denis-Galeraud Isabelle, et al.
Published: (2003)

Cholesterol de novo biosynthesis: a promising target to overcome the resistance to aromatase inhibitors in postmenopausal patients with estrogen receptor-positive breast cancer
by: Danila Coradini, et al.
Published: (2023)

Trastuzumab deruxtecan in recurrent uterine serous carcinoma resistant to trastuzmab based-chemotherapy
by: Blair McNamara, et al.
Published: (2023)

Impact of positive cytology in uterine serous carcinoma: A reassessment
by: Logan Corey, et al.
Published: (2021)

Estrogen/androgen balance in men with hyperestrogenism normalized by using letrozole of the aromatase inhibitor drug class
by: Z. Sh. Pavlova, et al.
Published: (2022)

Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma
by: Ana Amélia de Souza, et al.
Published: (2019)

Primary estrogen receptor-positive lung adenocarcinoma identified by immunohistochemical investigation of rare cutaneous metastasis to the breast in a patient with presumed recurrent estrogen receptor-positive breast cancer
by: Shu Ting Liang (Amy), et al.
Published: (2021)

Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma
by: Kelsey Musselman, et al.
Published: (2019)

Pembrolizumab with bevacizumab and cyclophosphamide for the treatment of recurrent ovarian clear cell carcinoma: A case series
by: Shannon M. Glynn, et al.
Published: (2024)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
by: Maho Shimizu, et al.
Published: (2021)

Carcinosarcoma arising from high-grade serous carcinoma of the ovary without estrogen receptor, WT-1, and PAX8 immunoreactivity
by: Naoya Harada, et al.
Published: (2022)

Schisandrol A Exhibits Estrogenic Activity via Estrogen Receptor α-Dependent Signaling Pathway in Estrogen Receptor-Positive Breast Cancer Cells
by: Dahae Lee, et al.
Published: (2021)

Mutation-Prone Positions Within the Estrogen Receptor
by: Viroj Wiwanitkit
Published: (2009)

Endometrial Progesterone and Estrogen Receptors in Relation to Hormonal Levels in Women with Unexplained Recurrent Miscarriage
by: Ihab Adel Gomaa, et al.
Published: (2023)

The role of omentectomy in the surgical treatment of uterine serous carcinoma
by: Ming Chen, et al.
Published: (2019)

Improved survival of patients with hypermutation in uterine serous carcinoma
by: Alessandro D. Santin, et al.
Published: (2015)

Intermittent Exercise Triggers Synthesis of CYP19 Aromatase as a Key Enzym for Estrogen Formation In Sprague Dawley Rat Bone Innovarectomy
by: Sri Widodo, et al.
Published: (2019)

Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report
by: Kayo Inoue, et al.
Published: (2020)

Targeted Next-Generation Sequencing Identifies Actionable Targets in Estrogen Receptor Positive and Estrogen Receptor Negative Endometriod Endometrial Cancer
by: Siti Syazani Suhaimi, et al.
Published: (2018)

Estrogen-Induced Uterine Vasodilation in Pregnancy and Preeclampsia
by: Yan Li, et al.
Published: (2022)

THE ROLE OF AROMATASE IN THE DEVELOPMENT OF ENDOMETRIOSIS
by: L. V. Adamyan, et al.
Published: (2017)

Bilateral Serous Retinal Detachment and Uterine Atony in Association with Preeclampsia
by: Şadıman Kıykaç Altınbaş, et al.
Published: (2012)

Superior vena cava syndrome associated with uterine serous carcinoma
by: Anya Laibangyang, et al.
Published: (2020)

Comparison of gonadotropin releasing hormone agonists (GNRHA) vs aromatase inhibitors on volume of uterine leiomyomas in premenopausal women
by: Uzma Hussain, et al.
Published: (2023)

Placental expression of estrogen receptor beta and its hormone binding variant - comparison with estrogen receptor alpha and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cells
by: Henley Donald C, et al.
Published: (2003)

Isolated recurrence of ovarian serous adenocarcinoma to adrenal gland
by: Rachel Borczuk, et al.
Published: (2022)

Uterine and placental expression of TRPV6 gene is regulated via progesterone receptor- or estrogen receptor-mediated pathways during pregnancy in rodents
by: Choi Kyung-Chul, et al.
Published: (2009)

Activation of estrogen receptor alpha induces beiging of adipocytes
by: Roberta S. Santos, et al.
Published: (2018)

Loss of skeletal muscle estrogen-related receptors leads to severe exercise intolerance
by: Jean-Sébastien Wattez, et al.
Published: (2023)

Human epidermal growth factor receptor 2 (Her2) testing for uterine serous carcinoma: Report of scenarios of unusual overexpression
by: M. Ruhul Quddus, et al.
Published: (2020)

Role of estrogen receptors in cancer: a special emphasis on the therapeutic potential of estrogen receptor β
by: Emdormi Rymbai, et al.
Published: (2022)

Breast metastases: A rare manifestation of advanced uterine serous carcinoma
by: Jennifer McEachron, et al.
Published: (2019)

Uterine Serous Papillary Carcinoma: A Retrospective Analysis of 22 Cases
by: Demir Özbasar, et al.
Published: (2008)

Ovarian high-grade serous carcinoma with estrogenic manifestations in a postmenopausal woman: A case report
by: Akihiro Takeda, et al.
Published: (2023)

Aromatase inhibitors in post-menopausal endometriosis
by: Devroey Paul, et al.
Published: (2011)

Aromatase inhibitors in stimulated IVF cycles
by: Tournaye Herman, et al.
Published: (2011)

New Insights into Estrogen/Estrogen Receptor Effects in the Cardiac and Skeletal Muscle
Published: (2020)